Mn porphyrin regulation of aerobic glycolysis: Implications on the activation of diabetogenic immune cells

Antioxidants and Redox Signaling

Volumn 19, Issue 16, 2013, Pages 1902-1915

  Delmastro Greenwood, Meghan M ^a,b   Votyakova, Tatyana ^a   Goetzman, Eric ^a   Marre, Meghan L ^a   Previte, Dana M ^a,b   Tovmasyan, Artak ^c   Batinic Haberle, Ines ^c   Trucco, Massimo M ^a   Piganelli, Jon D ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; ANTIOXIDANT; FATTY ACID; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCOSE TRANSPORTER 1; LACTIC ACID; MAMMALIAN TARGET OF RAPAMYCIN; MYC PROTEIN; PORPHYRIN; PORPHYRIN MANGANESE; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG; MANGANESE TETRAKIS-(N-ETHYL-2 PYRIDYL) PORPHYRIN; METALLOPORPHYRIN;

AEROBIC GLYCOLYSIS; AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENERGY; CELL ACTIVATION; CELL PROLIFERATION; CITRIC ACID CYCLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; FATTY ACID OXIDATION; FEMALE; GLUCOSE OXIDATION; GLYCOLYSIS; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; SPLEEN CELL; ANIMAL; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE;

ANIMALS; ANTIOXIDANTS; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 1; GLUCOSE; GLYCOLYSIS; METALLOPORPHYRINS; MICE; MICE, INBRED NOD; MICE, SCID;

EID: 84888588329     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.5167     Document Type: Article

References (82)

1. Batinic-Haberle I, Benov L, Spasojevic I, and Fridovich I. The ortho effect makes manganese(III) meso-tetrakis(Nmethylpyridinium-2-yl)porphyrin a powerful and potentially useful superoxide dismutase mimic. J Biol Chem 273: 24521-24528, 1998
2. Batinic-Haberle I, Reboucas JS, and Spasojevic I. Superoxide dismutase mimics: Chemistry, pharmacology, and therapeutic potential. Antioxid Redox Signal 13: 877-918, 2010
3. Batinic-Haberle I, Spasojevic I, Tse HM, Tovmasyan A, Rajic Z, St Clair DK, Vujaskovic Z, Dewhirst MW, and Piganelli JD. Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities. Amino Acids 42: 95-113, 2012
4. Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, and Roncarolo MG. Rapamycin promotes expansion of functional CD4 + CD25 + FOXP3 + regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 177: 8338-8347, 2006
5. Biswas M and Chan JY. Role of Nrf1 in antioxidant response element-mediated gene expression and beyond. Toxicol Appl Pharmacol 244: 16-20, 2010
6. Borregaard N and Herlin T. Energy metabolism of human neutrophilsduringphagocytosis. JClinInvest 70: 550-557, 1982
7. Bottino R, Balamurugan AN, Bertera S, Pietropaolo M, Trucco M, and Piganelli JD. Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound. Diabetes 51: 2561-2567, 2002
8. Bottino R, Balamurugan AN, Tse H, Thirunavukkarasu C, Ge X, Profozich J, Milton M, Ziegenfuss A, Trucco M, and Piganelli JD. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 53: 2559-2568, 2004
9. Bouzakri K, Austin R, Rune A, Lassman ME, Garcia-Roves PM, Berger JP, Krook A, Chibalin AV, Zhang BB, and Zierath Jr. Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle. Diabetes 57: 1508-1516, 2008
10. Buckley AF, Kuo CT, and Leiden JM. Transcription factor LKLF is sufficient to program T cell quiescence via a c-Mycdependent pathway. Nat Immunol 2: 698-704, 2001
11. Cam H, Balciunaite E, Blais A, Spektor A, Scarpulla RC, Young R, Kluger Y, and Dynlacht BD. A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell 16: 399-411, 2004
12. Case AJ, McGill JL, Tygrett LT, Shirasawa T, Spitz DR, Waldschmidt TJ, Legge KL, and Domann FE. Elevated mitochondrial superoxide disrupts normal T cell development, impairing adaptive immune responses to an influenza challenge. Free Radic Biol Med 50: 448-458, 2011
13. Cham CM, Driessens G, O'Keefe JP, and Gajewski TF. Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8 + T cells. Eur J Immunol 38: 2438-2450, 2008
14. Charbonnier LM and Le Moine A. Rapamycin as immunosuppressant in murine transplantation model. Methods Mol Biol 821: 435-445, 2012
15. Corcoran A and Cotter TG. Redox regulation of protein kinases. FEBS J 280: 1944-1965, 2013
16. Coudriet GM, He J, Trucco M, Mars WM, and Piganelli JD. Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: Implications for inflammatory mediated diseases. PLoS One 5: E15384, 2010
17. Culvenor JG and Weidemann MJ. Phytohaemagglutinin stimulation of rat thymus lymphocytes glycolysis. Biochim Biophys Acta 437: 354-363, 1976
18. Dang CV, Le A, and Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res 15: 6479-6483, 2009
19. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, Bordman Z, Fu J, Kim Y, Yen HR, Luo W, Zeller K, Shimoda L, Topalian SL, Semenza GL, Dang CV, Pardoll DM, and Pan F. Control of T(H)17/T(reg) balance by hypoxiainducible factor 1. Cell 146: 772-784, 2011
20. Day BJ, Batinic-Haberle I, and Crapo JD. Metalloporphyrins are potent inhibitors of lipid peroxidation. Free Radic Biol Med 26: 730-736, 1999
21. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, and Thompson CB. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7: 11-20, 2008
22. Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, Horton MR, Xiao B, Worley PF, and Powell JD. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol 12: 295-303, 2011
23. Delmastro MM and Piganelli JD. Oxidative stress and redox modulation potential in type 1 diabetes. Clin Dev Immunol 2011: 593863, 2011
24. Delmastro MM, Styche AJ, Trucco MM, Workman CJ, Vignali DA, and Piganelli JD. Modulation of redox balance leaves murine diabetogenic TH1 T cells ''LAG-3-ing'' behind. Diabetes 61: 1760-1768, 2012
25. Delmastro-Greenwood MM, Tse HM, and Piganelli JD. Effects of metalloporphyrins on reducing inflammation and autoimmunity. Antioxid Redox Signal 2013. [Epub ahead of print]; DOI: 10.1089/ars.2013.5257
26. Dobbs C and Haskins K. Comparison of a T cell clone and of T cells from a TCR transgenic mouse: TCR transgenic T cells specific for self-antigen are atypical. J Immunol 166: 2495-2504, 2001
27. Essa MM, Vijayan RK, Castellano-Gonzalez G, Memon MA, Braidy N, and Guillemin GJ. Neuroprotective effect of natural products against Alzheimer's disease. Neurochem Res 37: 1829-1842, 2012
28. Fan Y, Rudert WA, Grupillo M, He J, Sisino G, and Trucco M. Thymus-specific deletion of insulin induces autoimmune diabetes. EMBO J 28: 2812-2824, 2009
29. Field CJ, Wu G, Metroz-Dayer MD, Montambault M, and Marliss EB. Lactate production is the major metabolic fate of glucose in splenocytes and is altered in spontaneously diabetic BB rats. Biochem J 272: 445-452, 1990
30. Fox CJ, Hammerman PS, and Thompson CB. Fuel feeds function: Energy metabolism and the T-cell response. Nat Rev Immunol 5: 844-852, 2005
31. Frauwirth KA and Thompson CB. Regulation of T lymphocyte metabolism. J Immunol 172: 4661-4665, 2004
32. Ganapathy-Kanniappan S, Vali M, Kunjithapatham R, Buijs M, Syed LH, Rao PP, Ota S, Kwak BK, Loffroy R, and Geschwind JF. 3-bromopyruvate: A new targeted antiglycolytic agent and a promise for cancer therapy. Curr Pharm Biotechnol 11: 510-517, 2010
33. Gardner PR, Nguyen DD, and White CW. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc Natl Acad Sci U S A 91: 12248-12252, 1994
34. Guppy M, Greiner E, and Brand K. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur J Biochem 212: 95-99, 1993
35. Hamilton NM, Dawson M, Fairweather EE, Hamilton NS, Hitchin JR, James DI, Jones SD, Jordan AM, Lyons AJ, Small HF, Thomson GJ, Waddell ID, and Ogilvie DJ. Novel steroid inhibitors of glucose 6-phosphate dehydrogenase. J Med Chem 55: 4431-4445, 2012
36. Hashimoto T, Hussien R, Oommen S, Gohil K, and Brooks GA. Lactate sensitive transcription factor network in L6 cells: Activation of MCT1 and mitochondrial biogenesis. FASEB J 21: 2602-2612, 2007
37. Hay N and Sonenberg N. Upstream and downstream of mTOR. Genes Dev 18: 1926-1945, 2004
38. Hennessy BT, Smith DL, Ram PT, Lu Y, and Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4: 988-1004, 2005
39. Howell JJ and Manning BD. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol Metab 22: 94-102, 2011
40. Iritani BM, Delrow J, Grandori C, Gomez I, Klacking M, Carlos LS, and Eisenman RN. Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1. EMBO J 21: 4820-4830, 2002
41. Jaramillo MC, Briehl MM, Crapo JD, Batinic-Haberle I, and Tome ME. Manganese porphyrin, MnTE-2-PyP5 +, Acts as a pro-oxidant to potentiate glucocorticoid-induced apoptosis in lymphoma cells. Free Radic Biol Med 52: 1272-1284, 2012
42. Jaramillo MC, Frye JB, Crapo JD, Briehl MM, and Tome ME. Increased manganese superoxide dismutase expression or treatment with manganese porphyrin potentiates dexamethasone-induced apoptosis in lymphoma cells. Cancer Res 69: 5450-5457, 2009
43. Johnsen Lind A, Helge Johnsen B, Hill LK, Sollers Iii JJ, and Thayer JF. A user-friendly application for the extraction of kubios hrv output to an optimal format for statistical analysis -Biomed 2011. Biomed Sci Instrum 47: 35-40, 2011
44. Kim JY, Hickner RC, Cortright RL, Dohm GL, and Houmard JA. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 279: E1039-E1044, 2000
45. Krawczyk CM, Holowka T, Sun J, Blagih J, Amiel E, De-Berardinis RJ, Cross JR, Jung E, Thompson CB, Jones RG, and Pearce EJ. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115: 4742-4749, 2010
46. Kruger NJ and von Schaewen A. The oxidative pentose phosphate pathway: Structure and organisation. Curr Opin Plant Biol 6: 236-246, 2003
47. Lenzen S. Oxidative stress: The vulnerable beta-cell. Biochem Soc Trans 36: 343-347, 2008
48. Lin CY, Loven J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee TI, and Young RA. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151: 56-67, 2012
49. Lin MS, Tse HM, Delmastro MM, Bertera S, Wong CT, Lakomy R, He J, Sklavos MM, Coudriet GM, Pietropaolo M, Trucco MM, and Piganelli JD. A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice. Immunol Res 50: 213-220, 2011
50. Lin TA, Kong X, Haystead TA, Pause A, Belsham G, Sonenberg N, and Lawrence JC, Jr. PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science 266: 653-656, 1994
51. Liu TF, Vachharajani VT, Yoza BK, and McCall CE. NAD+ -dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J Biol Chem 287: 25758-25769, 2012
52. Lunt SY and Vander Heiden MG. Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27: 441-464, 2011
53. Maciver NJ, Jacobs SR, Wieman HL, Wofford JA, Coloff JL, and Rathmell JC. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 84: 949-957, 2008
54. Manganelli G, Fico A, Masullo U, Pizzolongo F, Cimmino A, and Filosa S. Modulation of the pentose phosphate pathway induces endodermal differentiation in embryonic stem cells. PLoS One 7: E29321, 2012
55. MoellerBJ,Batinic-HaberleI,Spasojevic I,RabbaniZN,Anscher MS,VujaskovicZ, andDewhirstMW.Amanganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness. Int J Radiat Oncol Biol Phys 63: 545-552, 2005
56. Nave BT, Ouwens M, Withers DJ, Alessi DR, and Shepherd PR. Mammalian target of rapamycin is a direct target for protein kinase B: Identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J 344 Pt 2: 427-431, 1999
57. Osthus RC, Shim H, Kim S, Li Q, Reddy R, Mukherjee M, Xu Y, Wonsey D, Lee LA, and Dang CV. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem 275: 21797-21800, 2000
58. Palm NW and Medzhitov R. Not so fast: Adaptive suppression of innate immunity. Nat Med 13: 1142-1144, 2007
59. Pearce EL. Metabolism in T cell activation and differentiation. Curr Opin Immunol 22: 314-320, 2010
60. Pfeiffer T, Schuster S, and Bonhoeffer S. Cooperation and competition in the evolution of ATP-producing pathways. Science 292: 504-507, 2001
61. Pierotti MA, Berrino F, Gariboldi M, Melani C, Mogavero A, Negri T, Pasanisi P, and Pilotti S. Targeting metabolism for cancer treatment and prevention: Metformin, an old drug with multi-faceted effects. Oncogene 32: 1475-1487, 2013
62. This reference has been deleted
63. Piganelli JD, Flores SC, Cruz C, Koepp J, Batinic-Haberle I, Crapo J, Day B, Kachadourian R, Young R, Bradley B, and Haskins K. A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone. Diabetes 51: 347-355, 2002
64. Rabinovitch A and Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet beta-cell destruction and insulindependent diabetes mellitus. Biochem Pharmacol 55: 1139-1149, 1998
65. Raza H, Prabu SK, John A, and Avadhani NG. Impaired mitochondrial respiratory functions and oxidative stress in streptozotocin-induced diabetic rats. Int J Mol Sci 12: 3133-3147, 2011
66. Scagliotti GV and Selvaggi G. Antimetabolites and cancer: Emerging data with a focus on antifolates. Expert Opin Ther Pat 16: 189-200, 2006
67. Schmid D, Burmester GR, Tripmacher R, Kuhnke A, and Buttgereit F. Bioenergetics of human peripheral blood mononuclear cell metabolism in quiescent, activated, and glucocorticoid-treated states. Biosci Rep 20: 289-302, 2000
68. Sekulic A, Hudson CC, Homme JL, Yin P, Otterness DM, Karnitz LM, and Abraham RT. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res 60: 3504-3513, 2000
69. Selman C, Tullet JM, Wieser D, Irvine E, Lingard SJ, Choudhury AI, Claret M, Al-Qassab H, Carmignac D, Ramadani F, Woods A, Robinson IC, Schuster E, Batterham RL, Kozma SC, Thomas G, Carling D, Okkenhaug K, Thornton JM, Partridge L, Gems D, and Withers DJ. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 326: 140-144, 2009
70. Sharma R and Vinayak M. Antioxidant alpha-tocopherol checks lymphoma promotion via regulation of expression of protein kinase C-alpha and c-Myc genes and glycolytic metabolism. Leuk Lymphoma 53: 1203-1210, 2012
71. Shriver LP and Manchester M. Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis. Sci Rep 1: 79, 2011
72. Sklavos MM, Bertera S, Tse HM, Bottino R, He J, Beilke JN, Coulombe MG, Gill RG, Crapo JD, Trucco M, and Piganelli JD. Redox modulation protects islets from transplant-related injury. Diabetes 59: 1731-1738, 2010
73. Sklavos MM, Tse HM, and Piganelli JD. Redox modulation inhibits CD8 T cell effector function. Free Radic Biol Med 45: 1477-1486, 2008
74. Tse HM, Milton MJ, and Piganelli JD. Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigen-presenting cells: Implication for their use in targeting oxidation-reduction reactions in innate immunity. Free Radic Biol Med 36: 233-247, 2004
75. Tse HM, Milton MJ, Schreiner S, Profozich JL, Trucco M, and Piganelli JD. Disruption of innate-mediated proinflammatory cytokine and reactive oxygen species third signal leads to antigen-specific hyporesponsiveness. J Immunol 178: 908-917, 2007
76. van Stipdonk MJ, Hardenberg G, Bijker MS, Lemmens EE, Droin NM, Green DR, and Schoenberger SP. Dynamic programming of CD8 + T lymphocyte responses. Nat Immunol 4: 361-365, 2003
77. Vander Heiden MG, Cantley LC, and Thompson CB. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324: 1029-1033, 2009
78. Wang J, Ren Z, Xu Y, Xiao S, Meydani SN, and Wu D. Epigallocatechin-3- gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4 + T-cell subsets. Am J Pathol 180: 221-234, 2012
79. Xuzhu G, Komai-Koma M, Leung BP, Howe HS, McSharry C, McInnes IB, and Xu D. Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function. Ann Rheum Dis 71: 129-135, 2012
80. Yan LJ, Levine RL, and Sohal RS. Oxidative damage during aging targets mitochondrial aconitase. Proc Natl Acad Sci U S A 94: 11168-11172, 1997
81. Zhao Y, Chaiswing L, Oberley TD, Batinic-Haberle I, St Clair W, Epstein CJ, and St. Clair D. A mechanism-based antioxidant approach for the reduction of skin carcinogenesis. Cancer Res 65: 1401-1405, 2005
82. Zheng Y, Collins SL, Lutz MA, Allen AN, Kole TP, Zarek PE, and Powell JD. A role for mammalian target of rapamycin in regulating T cell activation versus anergy. J Immunol 178: 2163-2170, 2007